目的:本研究旨在评估抗菌光动力疗法(aPDT)和益生菌在口臭治疗中的作用。
方法:52名参与者,年龄从18岁到25岁,选择呼出硫氢化物(H2S)≥112ppb。他们被分为4组(n=13):第1组:刮舌器;第2组:用aPDT治疗一次;第3组:含有唾液乳杆菌WB21(6.7x108CFU)和木糖醇(280mg)的益生菌胶囊,一天3次饭后,14天;第4组:用aPDT和益生菌胶囊治疗一次,共14天。在aPDT之前和之后,从舌背收集具有气相色谱(临床评估)和微生物样品的Halimetry,以及7、14和30天后。临床数据不符合正态分布;因此,使用Kruskal-Wallis检验(独立测量)和FriedmanANOVA(依赖测量)进行比较,然后进行适当的posthoc检验。必要时。对于微生物数据,由于数据未能遵循正态分布,Kruskal-Wallis等级和检验采用Dunn的后期检验进行。显著性水平为α=0.05。
结果:临床结果(halmetry)显示aPDT(p=0.0008)和/或刮舌(p=0.0006)可立即显着减少口臭。益生菌相对于初始水平没有差异(p=0.7530)。在对照预约中没有发现显著差异。牙龈卟啉单胞菌的数量,连翘坦菌,在整个分析过程中,树突状螺旋体和螺旋体没有改变(分别为p=0.1616,p=0.2829和p=0.2882)。
结论:aPDT和刮舌可立即减少口臭,但是在整个研究过程中细菌的数量没有减少,或者控制时间的差异,在临床和微生物学结果。新的临床试验是必要的,以更好地评估测试的疗法。
背景:临床试验NCT03996044。
OBJECTIVE: This study aimed to evaluate the effect of antimicrobial photodynamic therapy (aPDT) and the use of probiotics on the treatment of halitosis.
METHODS: Fifty-two participants, aged from 18 to 25 years, exhaling sulfhydride (H2S) ≥ 112 ppb were selected. They were allocated into 4 groups (n = 13): Group 1:
tongue scraper; Group 2: treated once with aPDT; Group 3: probiotic capsule containing Lactobacillus salivarius WB21 (6.7 x 108 CFU) and xylitol (280mg), 3 times a day after meals, for 14 days; Group 4: treated once with aPDT and with the probiotic capsule for 14 days. Halimetry with gas chromatography (clinical evaluation) and microbiological samples were collected from the dorsum of the
tongue before and after aPDT, as well as after 7, 14, and 30 days. The clinical data failed to follow a normal distribution; therefore, comparisons were made using the Kruskal-Wallis test (independent measures) and Friedman ANOVA (dependent measures) followed by appropriate posthoc tests, when necessary. For the microbiological data, seeing as the data failed to follow a normal distribution, the Kruskal-Wallis rank sum test was performed with Dunn\'s post-test. The significance level was α = 0.05.
RESULTS: Clinical results (halimetry) showed an immediate significant reduction in halitosis with aPDT (p = 0.0008) and/or
tongue scraper (p = 0.0006). Probiotics showed no difference in relation to the initial levels (p = 0.7530). No significant differences were found in the control appointments. The amount of Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola were not altered throughout the analysis (p = 0.1616, p = 0.2829 and p = 0.2882, respectively).
CONCLUSIONS: There was an immediate clinical reduction of halitosis with aPDT and
tongue scraping, but there was no reduction in the number of bacteria throughout the study, or differences in the control times, both in the clinical and microbiological results. New clinical trials are necessary to better assess the tested therapies.
BACKGROUND: Clinical Trials NCT03996044.